May 21, 2013
- Osaka, Japan, May 21, 2013--- Takeda Pharmaceutical Company Limited today announced new appointment of senior leadership. The details are as follows;
May 20, 2013
- San Francisco, California – May 18, 2013 – Takeda Pharmaceutical Company Limited (Takeda) and H. Lundbeck A/S (Lundbeck) today announced that the companies will be presenting new data from four studies that evaluated effectiveness in treating the overall symptoms of dep
May 16, 2013
- Osaka, Japan, May 16, 2013 --- Takeda Pharmaceutical Company Limited ("Takeda") announced today the results of a Phase III clinical trial (CCT-003) of fasiglifam (Development code:TAK-875) for the treatment of type 2 diabetes presented at the 56th Annual Meeting of the Japan Diabetes Socie
May 9, 2013
- Osaka, Japan, May 9, 2013 --- Takeda Pharmaceutical Company Limited (“Takeda”, “the Company”) today announced its “Vision 2020,” and commenced its Mid-Range Growth Strategy starting from fiscal 2013 that aims to realize where the company as
- Osaka, Japan, May 9, 2013 --- Takeda Pharmaceutical Company Limited (“Takeda”, “the Company”) announced today the consolidated financial results for the fiscal year ended March 31, 2013, and forecasts of consolidated results for the fiscal year ending March 31
- Osaka, Japan, May 9, 2013 – Takeda Pharmaceutical Company Limited (“Takeda”, TSE: 4502) announced that it has resolved at a meeting of the Board of Directors held today that, as of the fiscal year ending March 31, 2014 (fiscal year 2013, “FY2013”), i
- Osaka, Japan, May 9, 2013 – Takeda Pharmaceutical Company Limited (“Takeda”, “the Company”) announced today a revision to the consolidated financial forecasts for fiscal year ending March 31, 2014, (“fiscal 2013”) that were previo
- Osaka, Japan, May 9, 2013 --- Takeda Pharmaceutical Company Limited (“Takeda”) announced today that effective May 9, 2013, Anna Protopapas, currently Corporate Officer, Executive Vice President and Global Business Development Head, Takeda Pharmaceuticals International, Inc.* loca
May 8, 2013
- Osaka, Japan, May 8, 2013, Deerfield, IL and Fort Collins, CO, U.S.A., May 7, 2013 – Takeda Pharmaceutical Company Limited (“Takeda”) and Inviragen, Inc. (“Inviragen”) jointly announced today that Takeda, its wholly owned subsidiary Takeda America Ho
April 25, 2013
- Osaka, Japan, April 25, 2013 --- Takeda Pharmaceutical Company Limited today announced new appointment of senior leadership. The details are as follows;